ISSN: 2157-2526

Zeitschrift für Bioterrorismus und Bioverteidigung

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Indiziert in
  • CAS-Quellenindex (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Akademische Schlüssel
  • JournalTOCs
  • Forschungsbibel
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Ulrichs Zeitschriftenverzeichnis
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • SWB Online-Katalog
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • ICMJE
Teile diese Seite

Abstrakt

Detection and Identification of a Novel Pathogen

Anderson Avon

The rapid and accurate detection and identification of novel pathogens are critical for timely public health response and effective management of infectious diseases. In this study, we present a comprehensive approach for the detection and identification of a novel pathogen, leveraging advanced molecular techniques and bioinformatics analysis. First, we employed metagenomic sequencing to capture and sequence the entire genetic material present in clinical samples collected from affected individuals. Subsequently, we utilized state-of-the-art bioinformatics tools to analyze the metagenomic data, enabling the identification and characterization of the pathogen's genome. To validate the identification, we developed specific molecular assays, including polymerase chain reaction (PCR) and nextgeneration sequencing (NGS), targeting unique genetic markers of the novel pathogen. These assays were evaluated using a panel of known pathogens and clinical samples from patients with confirmed infections. Furthermore, we conducted a comprehensive phylogenetic analysis to assess the evolutionary relationship of the novel pathogen with other related species, shedding light on its potential origin and transmission dynamics. The detection and identification pipeline developed in this study demonstrated high sensitivity and specificity, accurately detecting and characterizing the novel pathogen from diverse clinical samples. Overall, this research provides a robust framework for the timely identification and characterization of emerging pathogens, facilitating rapid public health response and guiding appropriate interventions to mitigate the spread and impact of infectious diseases.